James T. VanderLugt

1.7k total citations
25 papers, 1.2k citations indexed

About

James T. VanderLugt is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, James T. VanderLugt has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in James T. VanderLugt's work include Cardiac electrophysiology and arrhythmias (10 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Cardiac Arrhythmias and Treatments (7 papers). James T. VanderLugt is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Cardiac Arrhythmias and Treatments (7 papers). James T. VanderLugt collaborates with scholars based in United States, Australia and China. James T. VanderLugt's co-authors include Bruce S. Stambler, Kimberly T. Perry, Mark A. Wood, Peter R. Kowey, Kenneth A. Ellenbogen, John R. Luderer, Patricia D. Kroboth, Annabelle Santos Volgman, William R. Lewis and Randall B. Smith and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

James T. VanderLugt

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James T. VanderLugt United States 14 918 203 58 53 47 25 1.2k
Rodolfo Rivera Italy 14 582 0.6× 398 2.0× 86 1.5× 61 1.2× 134 2.9× 45 1.2k
Weizhong Zhang China 12 436 0.5× 288 1.4× 90 1.6× 29 0.5× 26 0.6× 37 921
Laurence O’Toole United Kingdom 11 515 0.6× 75 0.4× 89 1.5× 90 1.7× 23 0.5× 18 698
J E Sealey United States 13 669 0.7× 192 0.9× 99 1.7× 24 0.5× 90 1.9× 16 1.0k
Jan‐Arne Björkman Sweden 16 522 0.6× 240 1.2× 179 3.1× 44 0.8× 45 1.0× 38 919
Gregory N. Beatch Canada 19 1.2k 1.3× 350 1.7× 37 0.6× 20 0.4× 57 1.2× 51 1.4k
Gert‐Hinrich Reil Germany 13 363 0.4× 105 0.5× 97 1.7× 22 0.4× 92 2.0× 39 676
M Nakashima Japan 9 237 0.3× 116 0.6× 33 0.6× 33 0.6× 58 1.2× 25 495
Michael Gwilt United Kingdom 10 367 0.4× 362 1.8× 52 0.9× 42 0.8× 67 1.4× 20 717
Kazuo Tsunoda Japan 15 642 0.7× 237 1.2× 96 1.7× 66 1.2× 144 3.1× 53 921

Countries citing papers authored by James T. VanderLugt

Since Specialization
Citations

This map shows the geographic impact of James T. VanderLugt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James T. VanderLugt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James T. VanderLugt more than expected).

Fields of papers citing papers by James T. VanderLugt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James T. VanderLugt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James T. VanderLugt. The network helps show where James T. VanderLugt may publish in the future.

Co-authorship network of co-authors of James T. VanderLugt

This figure shows the co-authorship network connecting the top 25 collaborators of James T. VanderLugt. A scholar is included among the top collaborators of James T. VanderLugt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James T. VanderLugt. James T. VanderLugt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
VanderLugt, James T., et al.. (2017). Pharmacokinetics and Bioequivalence of Branded and Generic Formulations of Dofetilide 0.5‐mg Capsules After Single‐Dose Administration in Healthy Subjects. Clinical Pharmacology in Drug Development. 7(3). 311–318. 1 indexed citations
2.
Shah, Raj C., Dawn Matthews, Randolph D. Andrews, et al.. (2014). An Evaluation of MSDC-0160, A Prototype mTOT Modulating Insulin Sensitizer, in Patients with Mild Alzheimer’s Disease. Current Alzheimer Research. 11(6). 564–573. 46 indexed citations
3.
Colca, Jerry R., et al.. (2013). Clinical Proof-of-Concept Study With MSDC-0160, a Prototype mTOT-Modulating Insulin Sensitizer. Clinical Pharmacology & Therapeutics. 93(4). 352–359. 61 indexed citations
4.
5.
MacDougall, Diane, Jeffrey C. Hanselman, Mark A. Milad, et al.. (2013). ETC-1002 Lowers LDL-Cholesterol and Beneficially Modulates Other Cardio-Metabolic Risk Factors in Hypercholesterolemic Subjects†. Journal of clinical lipidology. 7(3). 283–283.
6.
Colca, Jerry R., Rolf F. Kletzien, & James T. VanderLugt. (2009). A PPAr-sparing insulin sensitizer is effective in type 2 diabetic patients without causing weight gain. Canadian Journal of Diabetes. 33(3). 235–236. 3 indexed citations
7.
VanderLugt, James T., Thomas A. Mattioni, Stephen Denker, et al.. (1999). Efficacy and Safety of Ibutilide Fumarate for the Conversion of Atrial Arrhythmias After Cardiac Surgery. Circulation. 100(4). 369–375. 139 indexed citations
8.
Wood, Mark A., Bruce S. Stambler, Kenneth A. Ellenbogen, et al.. (1998). Suppression of inducible ventricular tachycardia by ibutilide in patients with coronary artery disease. American Heart Journal. 135(6). 1048–1054. 13 indexed citations
9.
10.
Stambler, Bruce S., Karen J. Beckman, Alan H. Kadish, et al.. (1997). Acute Hemodynamic Effects of Intravenous Ibutilide in Patients With or Without Reduced Left Ventricular Function. The American Journal of Cardiology. 80(4). 458–463. 39 indexed citations
11.
VanderLugt, James T., et al.. (1996). Relationship between subject age and QTc interval prolongation induced by the class III antiarrhythmic drug ibutilide.. Clinical Pharmacology & Therapeutics. 59(2). 164–164. 7 indexed citations
12.
Naccarelli, Gerald V., et al.. (1996). Electrophysiology and Pharmacology of Ibutilide. The American Journal of Cardiology. 78(8). 12–16. 67 indexed citations
13.
Kowey, Peter R., James T. VanderLugt, & John R. Luderer. (1996). Safety and Risk/Benefit Analysis of Ibutilide for Acute Conversion of Atrial Fibrillation/Flutter. The American Journal of Cardiology. 78(8). 46–52. 95 indexed citations
14.
Ellenbogen, Kenneth A., Henry F. Clemo, Bruce S. Stambler, Mark A. Wood, & James T. VanderLugt. (1996). Efficacy of Ibutilide for Termination of Atrial Fibrillation and Flutter. The American Journal of Cardiology. 78(8). 42–45. 67 indexed citations
15.
Stambler, Bruce S., et al.. (1996). Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation. Circulation. 94(7). 1613–1621. 337 indexed citations
16.
17.
18.
Ferry, James J., et al.. (1990). Influence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solution. Clinical Pharmacology & Therapeutics. 47(4). 439–446. 30 indexed citations
19.
Metzler, Carl M. & James T. VanderLugt. (1990). Medical and Statistical Design Issues in Clinical Pharmacology. Drug Information Journal. 24(2). 281–288. 1 indexed citations
20.
Lakings, Duane B., et al.. (1989). Pharmacokinetics of Furegrelate After Oral Administration to Normal Humans. Pharmaceutical Research. 6(1). 53–57. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rodolfo Rivera Breakdown of academic impact, for papers by Weizhong Zhang Breakdown of academic impact, for papers by Laurence O’Toole Breakdown of academic impact, for papers by J E Sealey Breakdown of academic impact, for papers by Jan‐Arne Björkman Breakdown of academic impact, for papers by Gregory N. Beatch Breakdown of academic impact, for papers by Gert‐Hinrich Reil Breakdown of academic impact, for papers by M Nakashima Breakdown of academic impact, for papers by Michael Gwilt Breakdown of academic impact, for papers by Kazuo Tsunoda
Rankless by CCL
2026